Ken Griffin’s Allergan plc AGN.PRA Stock Holding History

Ken Griffin’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-7,500	Closed	-$4.4M	–	9177
2017 Q4	$4.4M	Hold	7,500	–	–	﹤0.01%	2620
2017 Q3	$5.54M	Buy	+7,500	New	+$6.23M	﹤0.01%	2208
2017 Q1	–	Sell	-30,000	Closed	-$22.9M	–	8418
2016 Q4	$22.9M	Sell	30,000 -10,000	-25%	-$7.56M	0.02%	775
2016 Q3	$32.8M	Buy	+40,000	New	+$34.6M	0.03%	595
2016 Q2	–	Sell	-20,000	Closed	-$18.3M	–	7780
2016 Q1	$18.3M	Sell	20,000 -10,000	-33%	-$9.56M	0.02%	797
2015 Q4	$30.8M	Sell	30,000 -20,000	-40%	-$20.1M	0.03%	602
2015 Q3	$47.3M	Buy	50,000 +15,000	+43%	+$15.6M	0.04%	470
2015 Q2	$36.6M	Buy	+35,000	New	+$36.6M	0.03%	643

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Ken Griffin's AGN.PRA Position: Q1 2018 in Review

Ken Griffin sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 7,500 shares — an estimated $4.4M sold.

Ken Griffin first reported a position in AGN.PRA in Q2 2015 and held it in 8 quarters. The position peaked at $47.3M in Q3 2015. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Ken Griffin reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Ken Griffin sold 7,500 Allergan plc shares in Q1 2018, an estimated $4.4M.
Ken Griffin first reported a position in Allergan plc in Q2 2015 and held it in 8 quarters.
Ken Griffin's Allergan plc position peaked at $47.3M in Q3 2015.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Citadel Advisors's 13F filing for Q1 2018, filed 11 May 2018.